Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is being recorded.

Boston Scientific Corporation (BSX), a medical technology company, Wednesday reported net income of $566 million or $0.38 per share

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/19.DnqOsaYJ.js

Boston Scientific (NYSE:BSX) reported fiscal Q4 2024 results that surpassed analyst expectations. The company's shares swung between gains and losses in premarket trading Wednesday. The company reported earnings per share (EPS) of $0.

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO Kenneth Stein - Chief Medical Officer

Boston Scientific (BSX) reported stronger-than-expected fourth-quarter revenue on Wednesday amid a sharp gain in its cardiovascular segment, while guiding for a deceleration in top-line growth this year.

Boston Scientific (BSX) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.